Biotech industry.
Monitor FY13 appropriations process: FDA funding issues and drug approval/review oversight process. Monitor the potential outcomes for negotiations on altering sequestration targets via legislation.  Monitor plans for issues related to comprehensive tax reform, tax treatment of foreign-owned U.S. corporations, and tax extenders (R & D tax credit). Implementation of healthcare reform law. FDA Drug Approval and appeal oversight process.  Issues related to patient and physician choice in medical treatments.
BUD - Budget/Appropriations MED - Medical/Disease Research/Clinical Labs
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
SQUIRE PATTON BOGGS
2550 M STREET, NW, WASHINGTON, DC, 20037, US
KEVIN O'NEILL MANNY ROSSMAN (Staff,Crane,01-04;Staff,Lott,05-06;Ofce,Whip,07-09) KEVIN O'NEILL MANNY ROSSMAN (Staff,Crane,01-04;Staff,Lott,05-06;Ofce,Whip,07-09)
Staff,Crane,01-04;Staff,Lott,05-06;Ofce,Whip,07-09 Staff,Crane,01-04;Staff,Lott,05-06;Ofce,Whip,07-09